Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Pansy, J; Minkov, M; Dengg, R; Quehenberger, F; Lackner, H; Nebl, A; Sovinz, P; Schwinger, W; Urban, C; Benesch, M.
Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study.
Klin Padiatr. 2010; 222(6): 374-377.
Doi: 10.1055/s-0030-1267150
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Leading authors Med Uni Graz
- Pansy Jasmin
- Co-authors Med Uni Graz
- Benesch Martin
- Dengg Rosmarie
- Lackner Herwig
- Nebl Andrea Maria
- Quehenberger Franz
- Ritter-Sovinz Petra
- Schwinger Wolfgang
- Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background: Childhood immune thrombocytopenia (ITP) is a bleeding disorder characterized by decreased platelet counts. Assessment of the individual bleeding risk during the course of the disease would allow more accurately guiding treatment-related decisions in these patients. Patients and Methods: We conducted a pilot study and prospectively evaluated platelet counts and bleeding signs using an established bleeding (Buchanan) score in 30 patients with newly diagnosed ITP at 3 different time points (at diagnosis [TP1], on day 2-3 [TP2], and on day 5-8 [TP3]) during the first week after diagnosis. 15 patients received immune modulatory therapy. Results: Median platelet counts at the 3 different time points were 13, 19, 32 x 10(9)/L (untreated patients) and 2, 7, 37 x 10(9)/L (treated patients). Corresponding median cumulative bleeding scores were 5, 2, 0 (untreated patients) and 7, 6, 2 (treated patients). Cumulative median bleeding scores and platelet counts were inversely correlated in treated and untreated patients at all 3 time points. Cumulative median bleeding scores significantly decreased in both groups. Conclusions: Bleeding signs in children with newly diagnosed ITP rapidly improve within one week after diagnosis. Serial grading of bleeding severity seems to be useful to comprehensively assess and monitor the individual bleeding risk in these patients, but has to be evaluated and validated in a larger cohort.
- Find related publications in this database (using NLM MeSH Indexing)
- Adrenal Cortex Hormones - therapeutic use
- Child -
- Child, Preschool -
- Combined Modality Therapy -
- Female -
- Hemorrhage - diagnosis Hemorrhage - immunology Hemorrhage - therapy
- Humans -
- Immunization, Passive -
- Male -
- Pilot Projects -
- Platelet Count -
- Prospective Studies -
- Purpura, Thrombocytopenic, Idiopathic - diagnosis Purpura, Thrombocytopenic, Idiopathic - immunology Purpura, Thrombocytopenic, Idiopathic - therapy
- Find related publications in this database (Keywords)
- immune thrombocytopenia
- bleeding severity
- bleeding score
- bleeding risk
- children